Company profile: Atritech
1.1 - Company Overview
Company description
- Provider of proprietary technology focused on replacing long-term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke, including the WATCHMAN Left Atrial Appendage Closure Technology. Private company founded in 2000 and based in Minneapolis, Minnesota.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Atritech
Vesper Medical
HQ: United States
Website
- Description: Provider of venous stenting solutions for deep venous disease, centered on the purpose-built Vesper DUO Venous Stent System, a portfolio of self-expanding nitinol stents to improve luminal diameter in symptomatic venous outflow obstructions, including DUO-HYBRID and DUO-EXTEND, and the VIVID clinical trial evaluating safety and efficacy in iliofemoral occlusive disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vesper Medical company profile →
Cleveland HeartLab
HQ: United States
Website
- Description: Provider of specialty clinical laboratory and disease management services focused on novel biomarker technologies and proprietary cardiovascular diagnostic tests, including inflammation testing, Cardio IQ lipid particle analysis, genetic and metabolic testing, and cardiovascular disease management, plus biomarker development R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cleveland HeartLab company profile →
SIS Medical
HQ: Switzerland
Website
- Description: Provider of vascular disease treatment products, developed, produced, and sold through its subsidiaries; founded in 2005 and headquartered in Winterthur, Switzerland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SIS Medical company profile →
Annexin Pharmaceuticals
HQ: Sweden
Website
- Description: Provider of biotechnology focused on Annexin A5-based therapeutics. Develops ANXV, a human recombinant Annexin A5 that targets phosphatidylserine for acute treatment of cardiovascular diseases and is being investigated for retinal vein occlusion, cancer, and sickle cell disease. ANXV aims to protect cells, modulate immune responses, and reduce vascular inflammation and cellular stress.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Annexin Pharmaceuticals company profile →
Techdevice
HQ: France
Website
- Description: Provider of industrial equipment products for the transportation, medical, energy and data communications industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Techdevice company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Atritech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Atritech
2.2 - Growth funds investing in similar companies to Atritech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Atritech
4.2 - Public trading comparable groups for Atritech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →